Concord Biotech Limited, a prominent Active Pharmaceutical Ingredients (API) manufacturer through fermentation & semi-synthetic process and finished formulations, is listed with a premium of 21.45% at Rs 900.05 per share on BSE. On the NSE, the stock debuted at Rs 900.05, indicating an impressive increase of 21.46% compared to its initial public offering price of …